Development and validation for high selective quantitative determination of metformin in human plasma by cation exchanging with normal-phase LC/MS/MS
- 4 January 2005
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 36 (5), 1063-1072
- https://doi.org/10.1016/j.jpba.2004.09.007
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Rapid determination of metformin in human plasma by liquid chromatography−tandem mass spectrometry methodJournal of Chromatography B, 2004
- Fast liquid chromatographic-tandem mass spectrometric (LC–MS–MS) determination of metformin in plasma samplesJournal of Pharmaceutical and Biomedical Analysis, 2004
- Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetesExpert Opinion on Pharmacotherapy, 2003
- 1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic PropertiesJournal of Medicinal Chemistry, 2003
- Liquid chromatography/tandem mass spectrometric bioanalysis using normal‐phase columns with aqueous/organic mobile phases – a novel approach of eliminating evaporation and reconstitution steps in 96‐well SPERapid Communications in Mass Spectrometry, 2002
- Analysis of a basic drug by on‐line solid‐phase extraction liquid chromatography/tandem mass spectrometry using a mixed mode sorbentRapid Communications in Mass Spectrometry, 2002
- Pharmacokinetics and Pharmacodynamics of Glyburide/Metformin Tablets (Glucovance???) versus Equivalent Doses of Glyburide and Metformin in Patients with Type 2 DiabetesClinical Pharmacokinetics, 2002
- Clinical Pharmacokinetics of MetforminClinical Pharmacokinetics, 1996
- MetforminThe New England Journal of Medicine, 1996
- Pharmacokinetic Optimisation of Oral Hypoglycaemic TherapyClinical Pharmacokinetics, 1991